Search

everythinglearnresearchcommunity

for

Search:↓

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Juniperus plants contain compounds with potential for developing various medical treatments.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Men with hair loss may lack zinc, copper, and vitamin D; supplements could help.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Vaccination helps reduce long COVID symptoms in women with PCOS.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Microplastics in the Lebanese Mediterranean carry harmful pollutants, posing environmental and health risks.

Increasing Rps14 helps grow more inner ear cells and repair hearing cells in baby mice.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

FGF20 is essential for hair follicle stem cell growth and development in fine-wool sheep.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

CK7 and CK20 help identify and classify tumors for accurate cancer diagnosis.

A20 protein is crucial for normal skin and hair development.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.